SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants reported selection by The Clearing House for interoperability in its on-chain money initiative is driving attention, with traders highlighting potential bank adoption and QNTs limited supply. Bulls view the development as a major catalyst, while skeptics question whether the project will create direct demand for the token and point to its future rollout; the discussion also reflects sharp volatility and profit-taking after a steep rally.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation silicon-carbide power semiconductors is driving attention, with traders viewing the award as technology validation and a potential defense-market opening. Some are cautious that it is a prototype-development program with undisclosed financial terms, so its near-term revenue impact is unclear and the initial enthusiasm has met with profit-taking.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiaks Phase 3 DAYBREAK trial met its primary endpoints for two experimental wet AMD treatments, with Zenkuda showing potential for longer intervals between injections and a planned FDA filing adding to optimism. Traders celebrated the sharp repricing and speculated about a short squeeze, while skeptics questioned the drugs advantage over newer competitors and raised concerns about future financing and dilution.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas strategic equity investment and clinical-trial collaboration with Summit is driving attention, with traders welcoming the added financial backing and validation for ivonescimab. Some are speculating about a future buyout or short squeeze, while others note the deal is an investmentnot an acquisitionand debate how much it changes the drugs clinical and FDA risks.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Reports of production cuts and layoffs at Cleveland-Cliffs Hamilton, Ontario plant, attributed to damage from U.S. tariffs, are driving concern about the company. Some traders suggest more hot-rolled coil could be sold instead, while others focus on steel prices and upcoming earnings as potential offsets.

XPeng, Inc. is a global physical AI company, which engages in bringing artificial intelligence into the physical world to reshape future mobility and smart living. It developed a full-stack physical AI architecture spanning Turing AI chips, world foundation models, and integrated software and hardware applications. The firm's product portfolio includes smart EVs, robotaxis, and humanoid robots. The company's sales and services drives continuous technological innovation and fosters an open physical AI ecosystem, making life smarter, safer, and better for users worldwide. XPeng, Inc. was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPengs steep selloff and fresh lows are drawing attention, with traders citing disappointing Q2 results and weaker-than-expected Q3 guidance amid concerns about margins, losses, and China EV price competition. Bearish frustration over the sustained decline contrasts with dip-buying and optimism about the robotics business and overseas growth.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

CEO Dave Ricks comments that Lilly may pursue larger acquisitions with cash from its obesity-drug business have renewed discussion of the companys expansion beyond GLP-1s. Traders see the deals as a way to build future growth, while broader conversation weighs Lillys obesity-market strength against competition and its premium valuation.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

CEO CJ Desais abrupt departure for Meta, shortly before MongoDBs investor day, has triggered a sharp selloff and concerns about leadership stability, despite the company reaffirming its guidance and naming former CEO Dev Ittycheria interim chief. Traders are divided between viewing the transition as a serious uncertainty and calling the decline an overreaction, with some buying the dip on the belief that the business remains intact.

Anthropic

Anthropics confidential IPO filing and preparations for a major public listing are driving attention, with traders debating its rapid growth and potential scale. Some are bullish on the listing and related pre-IPO exposure, while skeptics question the valuation, heavy infrastructure spending and profitability.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SOFI is drawing attention amid a steep, persistent share-price decline, with traders debating whether the selloff is a buying opportunity or a sign of further weakness. Bears cite past dilution, insider selling, short pressure and a tough rate environment, while bulls argue the companys growth and fundamentals remain solid.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


bruxelles1

bruxelles